- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 237 results
Webinar
October 20, 2022
Federal M&A Outlook 2023
Webinar
September 29, 2022
Russia and Ukraine – Focus on the Energy Industry
Webinar
August 18, 2022
An Analysis of the Prescription Drug Pricing Provisions of the Inflation Reduction Act of 2022
Webinar
July 28, 2022
The Drug Supply Chain Security Act – Are Your Operations Ready for Final Implementation?
Webinar
July 27, 2022
The CMS SAFER Self-Assessment Attestation: New Requirements and New Opportunities for Patient Safety
Webinar
July 13, 2022
The Legal Life Cycle of Fleet Electrification
Webinar
June 29, 2022
Food & Beverage: 2022 Mid-Year Transactional Review with King & Spalding and Goldman Sachs
Webinar
June 22, 2022
Navigating the Privacy and Security Landscape: Recent Developments and Best Practices for Life Sciences Companies
Webinar
June 21, 2022
Telemedicine 2.0: What Providers Need to Know as They Design Their Post-Pandemic Telemedicine Strategies
Webinar
June 16, 2022
Let's Talk Tech: Understanding Non-Fungible Tokens (NFTs)
Webinar
May 24, 2022
Pre-empting and Navigating Joint Venture and Shareholder Disputes: An Indonesian Perspective
Webinar
May 18, 2022
Trending Now: Privacy and Cybersecurity Regulations